Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat Atrial Fibrillation
Not Recruiting
18-80 years
All
Phase
N/A
1 Location
Brief description of study
The purpose of the study is to provide data demonstrating the safety and effectiveness of the PulseSelect™ PFA System for the treatment of atrial fibrillation (AF)
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Atrial Fibrillation
-
Age: Between 18 Years - 80 Years
-
Gender: All
Male and Female Age 18-80 Atrial fibrillation, (AF)
Updated on
01 Aug 2024.
Study ID: 848462
